AKT1 and nasopharyngeal carcinoma: In the present study, our results showed that AKT Inhibitors and rapamycin abrogate cell invasion ability induced by TRIM29, which indicate inhibitors targeting the Akt/mTOR pathway may be potential for therapy of metastatic NPC expressing high levels of TRIM29.